Status:
TERMINATED
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Sanchez Cancer Center
Conditions:
Lung Cancer
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has...
Detailed Description
Subjects will be placed in a group to receive either the drug enbrel, or a placebo. The radiation therapy treatments are as they would be given if the person was not on a research study. The selection...
Eligibility Criteria
Inclusion
- Advanced lung, prostate, or bony metastasis for cancer
- Performance status (PS) of 3 or less
- Good lab test results with albumin of at least 2.5
- Radiation therapy of at least 4000Gy in 4 weeks
Exclusion
- Poor PS
- Planned radiation therapy for less than 4 weeks or 4000Gy
- Limited disease
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2005
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00127387
Start Date
May 1 2001
End Date
November 1 2005
Last Update
June 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229